Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Gem Pharmaceuticals LLC
DescriptionNon-cardiotoxic anthracycline derivative compound
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationSarcoma
Indication DetailsFirst-line treatment of soft tissue sarcoma (STS)
Regulatory Designation U.S. - Orphan Drug (First-line treatment of soft tissue sarcoma (STS))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today